Scientists at UC San Diego have found a gene pattern linked to stress and inflammation that may predict pancreatic cancer before it gets aggressive. The discovery centres on a gene called Integrin β3, ...

An estimated 61 million people live with hepatitis B, and 9 million with hepatitis C across the South-East Asia region, said the World Health Organization (WHO), stressing that progress is possible.

Discover the zodiac signs that often experience insecurity in relationships, including Cancer, Virgo, Libra, Scorpio, Pisces, ...

The Preventative Services Task Force helps determine which cancer screenings and preventative services insurers must cover.

Colorectal cancer screening and early detection can save lives. Anxiety about the process — or pushback from a doctor — shouldn't be barriers to getting tested.

Prostate cancer is the second leading cause of death in men right behind heart disease. Patients with this cancer often don’t find out until the disease has advanced quite a bit. But there are some ...

In a landmark achievement, a 60-year-old woman with advanced primary peritoneal carcinomatosis was successfully treated with Cytoreductive Surgery (CRS) combined with Hyperthermic Intraperitoneal ...

Numerous studies have linked high consumption of processed meats to a higher risk of cancer, including prostate cancer. These meats also tend to be high in saturated fat, which may promote tumor ...

Celcuity said on Monday its experimental combination treatment delayed the progression of a type of advanced breast cancer, sending the biotech firm's shares surging more than twofold in premarket ...

Vince Lombardi Cancer Foundation grant funding application deadline is July 31. Organization looking for more applicants.

The Alamo Drafthouse Cinema, located in the new plastic heart of Wrigleyville, tucked alongside the crush of tourists and bachelorette parties and bar crawls and soulless developments, is not the ...

A phase 3 trial of Celcuity’s breast cancer combination has hit its primary endpoints, blasting past the biotech’s bar for ...